[
  {
    "ts": "2025-11-24T12:45:00+00:00",
    "headline": "RVL Pharmaceuticals Announces Leadership Appointments to Accelerate Next Phase of Growth and Commercial Momentum",
    "summary": "RVL Pharmaceuticals, Inc and its affiliates (together, \"RVL\") today announced a series of senior leadership appointments to strengthen the organization and position the company for accelerated growth across its business, including its flagship product, Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1%.",
    "url": "https://finance.yahoo.com/news/rvl-pharmaceuticals-announces-leadership-appointments-124500429.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "1d8d0747-1d94-3b4e-9c56-5bb146867a46",
      "content": {
        "id": "1d8d0747-1d94-3b4e-9c56-5bb146867a46",
        "contentType": "STORY",
        "title": "RVL Pharmaceuticals Announces Leadership Appointments to Accelerate Next Phase of Growth and Commercial Momentum",
        "description": "",
        "summary": "RVL Pharmaceuticals, Inc and its affiliates (together, \"RVL\") today announced a series of senior leadership appointments to strengthen the organization and position the company for accelerated growth across its business, including its flagship product, Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1%.",
        "pubDate": "2025-11-24T12:45:00Z",
        "displayTime": "2025-11-24T12:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/80efeb6a95ce099da2d60c9bf9629f50",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Rc80fgTAsLDaU9xn4TeSqQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/80efeb6a95ce099da2d60c9bf9629f50.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VZWM2VsT7coc_hFN.xjnzg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/80efeb6a95ce099da2d60c9bf9629f50.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rvl-pharmaceuticals-announces-leadership-appointments-124500429.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rvl-pharmaceuticals-announces-leadership-appointments-124500429.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVLPQ"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T15:56:00+00:00",
    "headline": "Hip Replacement Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability, Product Launches, Key Persons, and Revenue Forecasts",
    "summary": "The Hip Replacement industry is poised for substantial growth, projected to reach US$ 10.24 billion by 2033, up from US$ 6.92 billion in 2024, at a CAGR of 4.45% between 2025 and 2033. This expansion is driven by increased awareness of procedures such as hip arthroplasty, which helps alleviate discomfort and enhance mobility for those with severe joint disorders. Factors such as rising obesity, orthopedic issues, and demand for surgical treatments contribute to market growth. Key players driving",
    "url": "https://finance.yahoo.com/news/hip-replacement-market-competitive-landscape-155600543.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "7e91dd04-6053-3245-b598-73abd3f8d08e",
      "content": {
        "id": "7e91dd04-6053-3245-b598-73abd3f8d08e",
        "contentType": "STORY",
        "title": "Hip Replacement Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability, Product Launches, Key Persons, and Revenue Forecasts",
        "description": "",
        "summary": "The Hip Replacement industry is poised for substantial growth, projected to reach US$ 10.24 billion by 2033, up from US$ 6.92 billion in 2024, at a CAGR of 4.45% between 2025 and 2033. This expansion is driven by increased awareness of procedures such as hip arthroplasty, which helps alleviate discomfort and enhance mobility for those with severe joint disorders. Factors such as rising obesity, orthopedic issues, and demand for surgical treatments contribute to market growth. Key players driving",
        "pubDate": "2025-11-24T15:56:00Z",
        "displayTime": "2025-11-24T15:56:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/7f169766d73c837dd0a9f7743b3f4a9c",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Hip Replacement Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IljbCfTyN8nkuHSKwiFhvw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7f169766d73c837dd0a9f7743b3f4a9c.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zRREBVg6LXAAG7EqCgmIsA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7f169766d73c837dd0a9f7743b3f4a9c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hip-replacement-market-competitive-landscape-155600543.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hip-replacement-market-competitive-landscape-155600543.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SN.L"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ZBH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T15:29:00+00:00",
    "headline": "Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue",
    "summary": "It has grown wildly, and it could keep growing.",
    "url": "https://www.fool.com/investing/2025/11/24/biotech-stock-nanobiotix-nbtx-is-up-660-this-year/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "6454d91d-49d6-36ef-ab7a-0f4106a0e23a",
      "content": {
        "id": "6454d91d-49d6-36ef-ab7a-0f4106a0e23a",
        "contentType": "STORY",
        "title": "Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue",
        "description": "",
        "summary": "It has grown wildly, and it could keep growing.",
        "pubDate": "2025-11-24T15:29:00Z",
        "displayTime": "2025-11-24T15:29:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b45e6f9c2ebebb69b4b72a0bff8cef2b",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Four people are cheering and jumping.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Fw7.8l8JgJhr76ndo..CGw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b45e6f9c2ebebb69b4b72a0bff8cef2b.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kw0onKF3Rl14zRwXfhWqxw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b45e6f9c2ebebb69b4b72a0bff8cef2b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/24/biotech-stock-nanobiotix-nbtx-is-up-660-this-year/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biotech-stock-nanobiotix-nbtx-660-152900321.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NANO.PA"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]